• Clarivate Plc recently announced a multi-year agreement with France’s Bibliographic Agency for Higher Education (Abes) to modernize the national academic library infrastructure using its Alma, Rapido and Primo cloud platform, consolidating services for thousands of higher education libraries and supporting a shift to a linked-data model.
• This win expands Clarivate’s role in France’s higher education ecosystem and highlights how its AI-enabled, cloud-based solutions are becoming embedded in critical public research infrastructure.
• Now we’ll explore how securing France’s national academic library modernization contract could influence Clarivate’s investment narrative built around AI-enabled subscription services.

The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.

Clarivate Investment Narrative Recap

To own Clarivate, you need to believe its AI-enabled, subscription-based tools can stay essential to research institutions despite funding pressure, open data, and high debt. The Abes win strengthens the case that its higher education and government-facing platforms are becoming embedded in national infrastructure, but it does little to reduce concerns about ongoing losses and the execution risk around Clarivate’s broader portfolio reshaping in the near term.

The guidance reaffirmed on July 6, 2026, for full-year revenue of US$2.30 billion to US$2.42 billion frames how meaningful the Abes contract might be in the context of Clarivate’s scale. While this single deal is unlikely to move the top line on its own, it reinforces the AI-and-SaaS catalyst that underpins those revenue expectations, in contrast to the risks tied to budget constraints and customers exploring lower cost alternatives.

Yet against this encouraging contract win, investors should also be aware that...

Clarivate's narrative projects $1.9 billion revenue and $142.7 million earnings by 2029. This assumes revenues will decrease by 7.4% yearly and requires an earnings increase of about $280 million from -$137.4 million today.

Uncover how Clarivate's forecasts yield a $2.50 fair value, a 8% upside to its current price.

Exploring Other Perspectives

Some of the lowest-estimate analysts paint a much tougher picture, expecting revenue to sit near US$2.4 billion and earnings only around US$26.8 million, so you should weigh this pessimism against contracts like Abes and consider how your own expectations compare.

Explore 4 other fair value estimates on Clarivate - why the stock might be worth just $2.40!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Clarivate research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Clarivate research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Clarivate's overall financial health at a glance.

No Opportunity In Clarivate?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.